Skip to main content
Fig. 5 | Journal of Nanobiotechnology

Fig. 5

From: A radioenhancing nanoparticle mediated immunoradiation improves survival and generates long-term antitumor immune memory in an anti-PD1-resistant murine lung cancer model

Fig. 5

Tumor growth curves and lung metastases in mice rechallenged with 344SQR cells. A Left, tumor growth curves for each of the surviving mice from the NBTXR3  +  HDXRT  +  LDXRT  +  ICIs treatment group and the four control mice after rechallenge with 344SQR cells in the right flank. Right, images of excised tumors from the control group. B Numbers (left) and images (right) of lung metastases at 36 days after tumor rechallenge. Data are expressed as means  ±  standard error of the mean (SEM). P  <  0.05 was considered statistically significant. *P  <  0.05. HDXRT high-dose radiotherapy; LDXRT low-dose radiotherapy; ICIs immune checkpoint inhibitors

Back to article page